New Study in Ewing Sarcoma Open to Enrollment

New Study in Ewing Sarcoma Open to Enrollment

SARC037 is a phase I study protocol to determine the recommended dose of trabectedin given as a 1-hour infusion in combination with low dose irinotecan. All patients enrolled will receive trabectedin combination …

Read more